EUVIMEDEUVIMED entdecken
Crossref

Flow cytometric immunophenotypic features of acute myeloid leukemia with mast cell differentiation

Jie Xu, Do Hwan Kim, Wei Wang, Shaoying Li, Pei Lin, Guilin Tang, Sergej Konoplev, Lianqun Qiu, Hong Fang, Sofia Garces, Vasiliki Leventaki, Shuyu E und 2 weitere

American Journal of Clinical Pathology · 2025

DOI: 10.1093/ajcp/aqae116 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Clinical Pathology, 2025. Verfasst von Jie Xu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, US. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Mast Cells. Die Arbeit nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Acute myeloid leukemia (AML) with mast cell (MC) differentiation was recently described as an aggressive subgroup of AML cases. The objectives of this study were to assess the flow cytometric immunophenotypic features of AML-MC cases.

Methods

We characterized the immunophenotypic features of 21 AML-MC cases by flow cytometry and compared them to 20 reactive/regenerating bone marrow specimens.

Results

The number of MCs detected by flow cytometry in AML-MC cases ranged from 0.4% to 21.1%, with a median of 3.5%, significantly higher than that of normal/reactive bone marrow (BM) (median, 0.01%; range, 0.000%-0.396%; P < .0001). Immunophenotypically, MCs in AML-MC cases demonstrated immaturity, differing from MCs in normal/reactive BMs, including dimmer CD45 (100% vs 0%), lower side scatter (100% vs 0%), more frequent CD34 (81% vs 20%), and CD123 (100% vs 10%) positivity, and more frequent uniform/increased CD38 expression (95% vs 20%) (all P ≤ .0001). CD2 (0/5) and CD25 (2/6, 1 uniform and 1 partial) were assessed in a subset of cases. The myeloblasts in AML-MC were typically CD34+CD117+HLA-DR+ with unusually frequent expression of CD56 (57%, all partial) and CD25 (63%, mostly partial), increased CD117 (62%), and decreased CD38 (86%). The MC percentage determined by flow cytometry correlated well with MCs detected by tryptase immunohistochemistry (r = 0.76, P < .001).

Conclusions

The MCs in AML-MC cases are characterized by dim CD45, low side scatter, CD34 and CD123 positivity, and uniform and increased CD38 expression. Flow cytometry is an excellent tool for identifying AML-MC cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteMast CellsHumansFlow CytometryImmunophenotypingMiddle AgedMaleFemaleAgedAdultCell DifferentiationAged, 80 and overYoung AdultAdolescentBone Marrow

Stichwörter der Autor:innen

acute myeloid leukemiaflow cytometrymast cell differentiation

Autor:innen und Institutionen

  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, US.

Zitieren

APA

Xu, J., Kim, D. H., Wang, W., Li, S., Lin, P., Tang, G., Konoplev, S., Qiu, L., Fang, H., Garces, S., Leventaki, V., E, S., Medeiros, L. J., & Wang, S. A. (2025). Flow cytometric immunophenotypic features of acute myeloid leukemia with mast cell differentiation. American Journal of Clinical Pathology. https://doi.org/10.1093/ajcp/aqae116

Vancouver

Xu J, Kim DH, Wang W, Li S, Lin P, Tang G, et al. Flow cytometric immunophenotypic features of acute myeloid leukemia with mast cell differentiation. American Journal of Clinical Pathology. 2025. doi:10.1093/ajcp/aqae116

BibTeX
@article{Xu2025,
  author = {Xu, Jie and Kim, Do Hwan and Wang, Wei and Li, Shaoying and Lin, Pei and Tang, Guilin and Konoplev, Sergej and Qiu, Lianqun and Fang, Hong and Garces, Sofia and Leventaki, Vasiliki and E, Shuyu and Medeiros, L Jeffrey and Wang, Sa A},
  title = {Flow cytometric immunophenotypic features of acute myeloid leukemia with mast cell differentiation},
  journal = {American Journal of Clinical Pathology},
  year = {2025},
  doi = {10.1093/ajcp/aqae116}
}
Kostenlos starten →